William D. Humphries
Executive Vice President and Company Group Chairma
Sales and Marketing
Valeant Pharmaceuticals International, Inc.
United States of America
Mr. William D. Humphries, also known as Bill, has been Executive Vice President at Valeant Pharmaceuticals International, Inc. since January 2, 2017 and serves as its Company Group Chairman of Dermatology. Mr. Humphries served as the Chief Executive Officer and President of Merz North America, Inc. from March 2012 to 2016. He served as a Member of Management Board at Merz GmbH & Co. KGaA. Mr. Humphries overseaw strategic direction and collaboration among three North American companies: Merz Pharmaceuticals, LLC, Merz Aesthetics, Inc. and Merz Pharma Canada, Ltd. He is a seasoned executive with more than 25 years of experience in the industry at leading companies in the specialty pharma space. He served as the President of Stiefel Laboratories, Inc., a wholly owned subsidiary of Glades Pharmaceuticals LLC since February 2008. He was responsible for strategy, business development, sales and marketing for all Stiefel products, such as DUAC(R) Topical Gel for acne, ROSAC(R) Cream with Sunscreens for rosacea, IMPRUV(R) Barrier Repair Cream and SARNA(R) Anti-Itch Lotion, the #1 dermatologist-recommended treatment for itchy skin. He served as a Senior Vice President of Commercial Operations at Stiefel Laboratories, Inc. since May 2004. He served as the Chief Commercial Officer of Stiefel Laboratories, Inc. since April 2007. He served as Vice President of the U.S. Skincare business at Allergan, Inc. Mr. Humphries spent 14 years in various positions with Allergan Pharmaceuticals, where he also served as Vice President of Sales and Marketing with hands-on involvement in strategy, execution and business development for Allergan's dermatology product line. Previously, he served on the management team at Dermik Laboratories, with division responsibilities in sales operations and product management. He serves as the Chairman of the boards of Merz Pharmaceuticals LLC, Merz Aesthetics and Merz Canada. He has been Independent Director at Aclaris Therapeutics, Inc. since September 1, 2016. He is a member of the Merz Pharma Board. He has been a Director of Stiefel Laboratories, Inc. since 2006 and Clearside BioMedical, Inc. since January 2012. He serves on the boards of The American Skin Association. He also serves on the boards of BioSouth and the Gwinnett County (Georgia) Chamber of Commerce and the board of trustees for Georgia Gwinnett College. Mr. Humphries holds an MBA from Pepperdine University in Malibu, California and a BA from Bucknell University, Lewisburg, Pennsylvania.
Sales and Marketing